| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $992,397 ) |
| | 2023 | 2023 | AEON RESPIRE, INC. | 1085 ROTELLA ST | NEWBURY PARK | CA | 91320-5527 | VENTURA | USA | R44HL156372 | Inhalation Repurposing of An Approved Drug to Treat Severe Asthma | 000 | 3 | NIH | 12/23/2022 | $992,767 |
| | 2023 | 2021 | AEON RESPIRE INC | 1085 ROTELLA ST | NEWBURY PARK | CA | 91320-5527 | VENTURA | USA | R44HL156372 | Inhalation Repurposing of An Approved Drug to Treat Severe Asthma | 001 | 1 | NIH | 2/2/2023 | -$370 |
|
| Issue Date FY: 2022 ( Subtotal = $1,193,081 ) |
| | 2022 | 2022 | AEON RESPIRE, INC. | 1085 ROTELLA ST | NEWBURY PARK | CA | 91320-5527 | VENTURA | USA | R44HL156372 | Inhalation Repurposing of An Approved Drug to Treat Severe Asthma | 000 | 2 | NIH | 12/16/2021 | $1,193,081 |
|
| Issue Date FY: 2021 ( Subtotal = $276,752 ) |
| | 2021 | 2021 | AEON RESPIRE, INC. | 1085 ROTELLA ST | NEWBURY PARK | CA | 91320-5527 | VENTURA | USA | R44HL156372 | Inhalation Repurposing of An Approved Drug to Treat Severe Asthma | 000 | 1 | NIH | 1/6/2021 | $276,752 |
|
|
